Paradigm BioCapital Advisors LP 13D and 13G filings for LENZ Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:32 pm Sale | 2025-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,073,461 3.800% | -346,371 (-24.40%) | Filing |
| 2025-03-27 4:21 pm Purchase | 2025-03-20 | 13G | LENZ Therapeutics, Inc. LENZ | Paradigm BioCapital Advisors LP | 1,419,832 5.200% | 1,419,832 (New Position) | Filing |